BioNTech Affirms Vaccine Guidance as Q1 2022 Revenue Hits €6.4B
(BioNTech) BioNTech expects to hit its 2022 vaccine revenue guidance of between 13 billion euros and 17 billion euros. The affirmed guidance happens after BioNTech reported total revenues of 6.375…